The University of Jordan (UJ) marked a significant scientific milestone with the inauguration of the first Biosafety Level 3 (BSL-3) virus research laboratory in the history of Jordanian universities. The facility, located at the Hamdi Mango Center for Scientific Research, was officially opened on Sunday by UJ President Prof. Nathir Obeidat.
The inauguration ceremony was attended by UJ vice presidents, several deans, and members of the academic staff, who toured the facility and were briefed on its advanced equipment and high-containment safety features in line with international biosafety standards.
Obeidat emphasised the strategic importance of the lab, describing it as a qualitative leap in UJ’s research infrastructure and a testament to the university’s ongoing commitment to scientific excellence in the fields of health and biological sciences.
“We are proud to be the first Jordanian university to establish such a facility,” he said. “This lab will offer a safe and advanced environment for conducting specialised research on high-risk viruses, and will enhance national preparedness for future pandemics and biological threats.”
The laboratory was constructed under the supervision of UJ’s Engineering Department and meets the biosafety requirements set by leading international agencies, including the NIH, CDC, and OSHA. The project was led technically by researcher Ms. Bashayer Abu Rmeileh.
Director of the Hamdi Mango Center, Prof. Rida Shibli, described the lab as a vital scientific platform that will open new avenues for research. “This facility significantly elevates the university’s capabilities in virology and epidemiology, further positioning UJ as a regional leader in scientific research,” he said.
Equipped with a negative pressure system, HEPA filtration, isolated biosafety cabinets, Real-Time PCR machines, precision microscopes, and an environmental sterilisation station, the lab is designed to ensure maximum safety and efficiency.
The new facility is expected to serve as a foundation for advanced research in virology, epidemiology, and vaccine development, reinforcing UJ’s role as a national center of excellence in scientific research and innovation.